Caveat regarding CMS Merit-based Incentive Payment Systems incidental adrenal nodule measure

Joseph Holman; Roberto Salvatori; Elliot K. Fishman; Pamela T. Johnson

doi:10.1007/s00261-018-1834-3

Caveat regarding CMS Merit-based Incentive Payment Systems incidental adrenal nodule measure

Joseph Holman, Roberto Salvatori, Elliot K. Fishman, Pamela T. Johnson

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Current Medicare MIP measures encourage radiologists not to recommend follow-up for ≤ 1 cm adrenal nodules. However, a radiologist may be the first to discover a small, subclinical pheochromocytoma. As such, recognition of the enhancement pattern of pheochromocytoma is important to ensure detection and properly guide management, which begins with clinical and laboratory assessment for elevated catecholamines.

Original language	English (US)
Pages (from-to)	1152-1154
Number of pages	3
Journal	Abdominal Radiology
Volume	44
Issue number	3
DOIs	https://doi.org/10.1007/s00261-018-1834-3
State	Published - Mar 1 2019

Keywords

Computed tomography (CT)
Incidental adrenal nodule
Merit-based Incentive Payment Systems (MIPS)
Pheochromocytoma

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging
Gastroenterology
Urology

Access to Document

10.1007/s00261-018-1834-3

Cite this

@article{9c15304548e04850871638739046dcd2,

title = "Caveat regarding CMS Merit-based Incentive Payment Systems incidental adrenal nodule measure",

abstract = "Current Medicare MIP measures encourage radiologists not to recommend follow-up for ≤ 1 cm adrenal nodules. However, a radiologist may be the first to discover a small, subclinical pheochromocytoma. As such, recognition of the enhancement pattern of pheochromocytoma is important to ensure detection and properly guide management, which begins with clinical and laboratory assessment for elevated catecholamines.",

keywords = "Computed tomography (CT), Incidental adrenal nodule, Merit-based Incentive Payment Systems (MIPS), Pheochromocytoma",

author = "Joseph Holman and Roberto Salvatori and Fishman, {Elliot K.} and Johnson, {Pamela T.}",

note = "Funding Information: Conflict of interest Joseph Holman and Roberto Salvatori have nothing to disclosures. Elliot K. Fishman received grant funding from GE Healthcare and Siemens and Founder and stockholder of HipGraphics. Pamela T. Johnson is a Consultant to Oliver Wyman. Publisher Copyright: {\textcopyright} 2018, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2019",

month = mar,

day = "1",

doi = "10.1007/s00261-018-1834-3",

language = "English (US)",

volume = "44",

pages = "1152--1154",

journal = "Abdominal Radiology",

issn = "2366-004X",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - Caveat regarding CMS Merit-based Incentive Payment Systems incidental adrenal nodule measure

AU - Holman, Joseph

AU - Salvatori, Roberto

AU - Fishman, Elliot K.

AU - Johnson, Pamela T.

N1 - Funding Information: Conflict of interest Joseph Holman and Roberto Salvatori have nothing to disclosures. Elliot K. Fishman received grant funding from GE Healthcare and Siemens and Founder and stockholder of HipGraphics. Pamela T. Johnson is a Consultant to Oliver Wyman. Publisher Copyright: © 2018, Springer Science+Business Media, LLC, part of Springer Nature.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Current Medicare MIP measures encourage radiologists not to recommend follow-up for ≤ 1 cm adrenal nodules. However, a radiologist may be the first to discover a small, subclinical pheochromocytoma. As such, recognition of the enhancement pattern of pheochromocytoma is important to ensure detection and properly guide management, which begins with clinical and laboratory assessment for elevated catecholamines.

AB - Current Medicare MIP measures encourage radiologists not to recommend follow-up for ≤ 1 cm adrenal nodules. However, a radiologist may be the first to discover a small, subclinical pheochromocytoma. As such, recognition of the enhancement pattern of pheochromocytoma is important to ensure detection and properly guide management, which begins with clinical and laboratory assessment for elevated catecholamines.

KW - Computed tomography (CT)

KW - Incidental adrenal nodule

KW - Merit-based Incentive Payment Systems (MIPS)

KW - Pheochromocytoma

UR - http://www.scopus.com/inward/record.url?scp=85058016345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058016345&partnerID=8YFLogxK

U2 - 10.1007/s00261-018-1834-3

DO - 10.1007/s00261-018-1834-3

M3 - Article

C2 - 30523373

AN - SCOPUS:85058016345

SN - 2366-004X

VL - 44

SP - 1152

EP - 1154

JO - Abdominal Radiology

JF - Abdominal Radiology

IS - 3

ER -

Caveat regarding CMS Merit-based Incentive Payment Systems incidental adrenal nodule measure

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this